Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by KayakerBCon Nov 20, 2015 5:49pm

105 Views

Post# 24311015

RE:RE:RE:RE:RE:The Agoracom board!!!! ,,,, Hmmmmmmmmmm!!

"....I now have my new head phones on!!, and good to see that the orca spit KBC out once again,,,,,its got to be he just tastes sour...."

Oh narmac, do I really have to explain this? It kinda wrecks the joke. I suggested you buy the "Alternate Viewpoint-Cancelling Headphones" for OTHER people, the ones who don't want to hear contrary opinions. My post was in SUPPORT of you (and fuzzy and G1945V). They wear the heaphones, they don't hear any contrary opinions, you get to post what you like.

Bullboard Posts

Canadian artificial intelligence ETFs